Current and emerging pharmacological treatments for sarcoidosis: a review - Wikidata - wikimedia - TriplyDB

Current and emerging pharmacological treatments for sarcoidosis: a review

Current and emerging pharmacological treatments for sarcoidosis: a review

http://www.wikidata.org/entity/Q24633717

about

Advances in the diagnosis and treatment of sarcoidosis Cardiac sarcoidosis: clinical manifestations, imaging characteristics, and therapeutic approach Nonsteroidal therapy of sarcoidosis.Mononeuritis multiplex as the first presentation of refractory sarcoidosis responsive to etanercept The effect of corticosteroids on quality of life in a sarcoidosis clinic: the results of a propensity analysis Chronic signaling via the metabolic checkpoint kinase mTORC1 induces macrophage granuloma formation and marks sarcoidosis progression.Targeting CD4(+) T cells for the treatment of sarcoidosis: a promising strategy?Clinical and Economic Evaluation of Repository Corticotropin Injection: A Narrative Literature Review of Treatment Efficacy and Healthcare Resource Utilization for Seven Key Indications Sarcoidosis: an update on current pharmacotherapy options and future directions.Managing fatigue in sarcoidosis - A systematic review of the evidence.A patient with a red eye and pulmonary oedema Sarcoidosis in A. C. Milan (1899)?

P2860

Q27026974-A55AB740-5328-4060-AE76-5CAC6A39BC54 Q30423870-10E0B741-0D1C-4EC9-BCE0-C22FD4772FD5 Q34049971-F7A299B1-D4ED-4DCD-96CD-D1098B8B0654 Q34768871-80D2D52F-B879-46DC-B481-041AF9A33FC1 Q35660312-B16203FC-ED06-4E7D-AE59-9B1B4BD674D6 Q37660352-68E710DA-453D-4FB3-8F30-6975A4A570DB Q38311906-2F33D2BA-C689-40F8-9163-E8A0D35F3AB5 Q38703169-B2BED8A4-3AD4-4532-8E77-C88B6FB4F76E Q38798146-BF7D822A-AB4A-4C08-AB01-83025F9860A3 Q38923440-89E2E62B-6287-489C-9F60-2E8061C4D742 Q42415939-92F8C619-A063-42F2-8CA7-AF6AABB60C7F Q50296507-30A292A1-4C6E-443E-8D6A-D107E2ACA450

P2860

Current and emerging pharmacological treatments for sarcoidosis: a review

http://www.wikidata.org/entity/Q24633717

description

2013 nî lūn-bûn

@nan

2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Current and emerging pharmacological treatments for sarcoidosis: a review

@ast

Current and emerging pharmacological treatments for sarcoidosis: a review

@en

Current and emerging pharmacological treatments for sarcoidosis: a review

@nl

type

label

Current and emerging pharmacological treatments for sarcoidosis: a review

@ast

Current and emerging pharmacological treatments for sarcoidosis: a review

@en

Current and emerging pharmacological treatments for sarcoidosis: a review

@nl

prefLabel

Current and emerging pharmacological treatments for sarcoidosis: a review

@ast

Current and emerging pharmacological treatments for sarcoidosis: a review

@en

Current and emerging pharmacological treatments for sarcoidosis: a review

@nl

P1433

Q24633717-B35AADE4-1A1A-4C25-9D6D-2EA2C238FE88

P1476

Q24633717-F3931F08-1DD4-4F8D-846E-7B4A754D32C6

P2093

Q24633717-62314BDC-266B-4C66-A145-00063DC631F6

Q24633717-EF974972-BFCE-4F7E-B70E-526F5DF5FDC4

Q24633717-F6BAEE38-4277-4E72-B207-56B319B65FB1

P2860

Q24633717-0017A336-0F7C-4422-AD8F-B116F4B4FCB9

Q24633717-03CDEBF3-06DC-4360-837D-08DF3F727603

Q24633717-06FF7614-8BD6-4CA2-811D-0E7DB8518E94

Q24633717-0C0361A2-01D0-47BF-9749-1EE864EC5A93

Q24633717-0D8AFB49-9D73-492B-A334-E93D90DECF79

Q24633717-28B54AB0-71E5-4D76-9303-F846AA291CD7

Q24633717-2A258689-6BB3-439E-B649-5E1C6A23C538

Q24633717-2BE04E5E-9F3C-4A6C-A6A6-997763B12131

Q24633717-2E64A211-758B-4367-8321-65A85A70DB18

Q24633717-2E8C96DD-16CB-4EA5-9222-A2F98629DEC2

P304

Q24633717-50F85E19-BE90-45A9-B4E8-803C7CC1D0BE

P31

Q24633717-863384DF-4AB8-45DE-8F84-65ACCE679212

P356

Q24633717-ACFF8922-4898-418E-A21D-ED98E9D6BD09

P407

Q24633717-18240E13-F75C-4DAA-9B6A-A3FCEA5106B7

P478

Q24633717-F82AE0F6-71BC-47AD-884E-CFE274067B38

P50

Q24633717-3D18EEC2-2260-41B4-9C6D-6999A527517E

P577

Q24633717-61085D82-FC4E-4831-82A6-E762B88EF417

P698

Q24633717-6409DECD-85BD-4ABE-88E1-6C20AE0959DC

P921

Q24633717-034A687D-8326-4EF4-8FC9-7F5640446BCE

Q24633717-0D1E777B-4BF0-4242-98A7-6E06FF6B95D4

Q24633717-2647D49D-D23F-4AF0-93D2-4F0E44C23BD5

Q24633717-7291BD3D-0BCC-4AC1-A1FA-5B8593C1C21B

P932

Q24633717-21987D05-A9E9-4D55-8E83-0AC9E30BF74E

P356

P1433

Drug Design, Development and Therapy

P1476

Current and emerging pharmacological treatments for sarcoidosis: a review

@en

P2093

Kerry Barba

http://www.w3.org/2001/XMLSchema#string

Romel Gobunsuy

http://www.w3.org/2001/XMLSchema#string

Scott H Beegle

http://www.w3.org/2001/XMLSchema#string

P2860

Corticosteroids for pulmonary sarcoidosis

Rheumatologic manifestations of sarcoidosis

A concise review of pulmonary sarcoidosis

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

The use of tetracyclines for the treatment of sarcoidosis.

Serum amyloid A regulates granulomatous inflammation in sarcoidosis through Toll-like receptor-2.

ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders.

Regulation of alveolar macrophage transforming growth factor-beta secretion by corticosteroids in bleomycin-induced pulmonary inflammation in the rat.

Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement.

Neurological deficits during treatment with tumor necrosis factor-alpha antagonists.

P304

325-338

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/DDDT.S31064

http://www.w3.org/2001/XMLSchema#string

P407

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-04-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23596348

http://www.w3.org/2001/XMLSchema#string

P921

P932

3627473

http://www.w3.org/2001/XMLSchema#string